Claude Franceschi: Comparing the Efficacy of CHIVA and Conventional Stripping and Ablation Techniques
Claude Franceschi, Angiologist Consultant Teacher at Center Marie‑Thérèse, shared a post on LinkedIn about a recent article by Jinghe Zhu et al, published in Annals of Vascular Surgery:
“Preserving the great saphenous vein (GSV), which is the first-choice conduit for potential future arterial grafting, is possible with CHIVA.
Systematic review and meta-analysis comparing the efficacy of CHIVA and conventional stripping and ablation techniques
Objective: Chronic venous disease (CVD), particularly primary lower extremity varicose veins, is a prevalent global health issue. The CHIVA technique is a hemodynamic-based, vein-preserving strategy proposed as a minimally invasive alternative to traditional treatments such as high ligation and stripping (HLS) or endovenous thermal ablation (e.g., radiofrequency or laser).
The CHIVA technique is designed to treat varicose veins while preserving the great saphenous vein (GSV), which is the first-choice conduit for potential future arterial grafting, especially at the infra-inguinal level. It offers theoretical advantages of reduced trauma, fewer complications, and lower recurrence potential. This systematic review aims to evaluate the efficacy and safety of CHIVA relative to established techniques based on current evidence.”
Title: Systematic Review and Meta-Analysis Comparing the Efficacy of CHIVA and Conventional Stripping and Ablation Techniques
Authors: Jinghe Zhu, Hongjie Cui, Menglong Li, Yingfeng Wu
Read the Full Article on Annals of Vascular Surgery․
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis